Clinical Trial

Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye

Study acronym: CAMOMILE-2
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Prospective, multicenter, randomized, vehicle-controlled, double-masked, study of CAM-101 topical ophthalmic solution compared to vehicle control followed by crossover to long-term follow-up open-label treatment with CAM-101 for one year.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-25; most recent amendment 2026-06-11.
Trial Details
NCT Number NCT06903611
Lead Sponsor Cambium Bio Limited
Conditions Dry Eye Disease, Dry Eye, Dry Eyes Chronic, Dry Eye Syndromes
Enrollment 475 participants
Start Date 2026-10-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-12